Skip to Main Content


  • Consider the diagnosis of malaria in any acutely febrile patient with a history of recent travel to a malarious area or who might have been infected through blood transfusion, needlestick, or other nosocomial parenteral exposure.
  • Transfer severely ill patients to an ICU and make a rapid clinical assessment, including spot measurement of blood glucose.
  • If the diagnosis of severe falciparum malaria is proved or suspected, initiate antimalarial chemotherapy using optimal doses of an appropriate agent (licensed quinine or quinidine or an artemisinin derivative such as artesunate on a named-patient basis) administered intravenously, using a loading dose. Monitor the clinical and parasitologic responses.
  • Prevent, or detect early and treat, the numerous complications (especially generalized convulsions, hypoglycemia, hyperpyrexia, and secondary bacterial infections).
  • Ensure correct fluid, electrolyte, and acid-base balance. Control fluid replacement to prevent circulatory overload and pulmonary edema. Anticipate renal and respiratory failure.
  • Expert nursing care of the unconscious patient is essential.
  • Avoid the use of potentially harmful ancillary treatments of unproven benefit, such as corticosteroids, heparin, and epinephrine.


Malaria is a mosquito-borne protozoal infection caused in humans by four species of Plasmodium: P. falciparum, P. vivax, P. malariae, or P. ovale.1 Only P. falciparum causes life-threatening malaria, but other species can cause severe illness in debilitated individuals. Plasmodium sporozoites, inoculated by female Anopheles mosquitoes during their blood meal, invade hepatocytes where they mature into schizonts, and after 6 to 16 days rupture to release merozoites into the bloodstream. In the cases of P. vivax and P. ovale, some sporozoites remain dormant in the liver for months or years in the form of hypnozoites, and can give rise to relapsing infections months or even years later. Plasmodium falciparum and P. malariae may persist as inapparent low-grade parasitemias to cause symptomatic recrudescences. However, these species do not persist in the liver. The erythrocytic cycle consists of invasion, development from rings to mature pigmented multinucleated schizonts, and rupture with release of 4 to 32 merozoites, depending on the species. These invade erythrocytes to produce repeated cycles of infection, or develop into male and female gametocytes. Merozoites cannot reinvade the liver from the blood. Erythrocytes containing mature trophozoites and schizonts of P. falciparum are sequestered in the tissues. Gametocytes taken up by mosquitoes complete a sexual cycle producing sporozoites which are injected with the mosquito's saliva during a blood meal. The usual intervals between the mosquito bite and the appearance of parasitemia are 10 days for P. falciparum, 8 to 13 days for P. vivax, 9 to 14 days for P. ovale, and 15 to 16 days for P. malariae. Minimal intervals between the bite and first symptom (incubation period) are a few days longer.




Malaria is endemic throughout tropical countries except in Pacific Islands east of Vanuatu (Fig. 58-1). P. falciparum is the most common cause of malaria in Africa, Haiti, some parts of South America, Southeast Asia, and New Guinea, but is now absent ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessAnesthesiology Full Site: One-Year Subscription

Connect to the full suite of AccessAnesthesiology content and resources including procedural videos, interactive self-assessment, real-life cases, 20+ textbooks, and more

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessAnesthesiology

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.